High tetracycline resistance percentages in Neisseria gonorrhoeae in Europe: is doxycycline post-exposure prophylaxis unlikely to reduce the incident gonorrhoea cases?
Authors:
- Magnus UnemoMUMagnus Unemo
- Eszter BallaEBEszter Balla
- Beatrice BercotBBBeatrice Bercot
- Maria José BorregoMBMaria José Borrego
- Dominique CaugantDCDominique Caugant
- Brendan CrowleyBCBrendan Crowley
- Irith De BaetselierIBIrith De Baetselier
Open Access
- 13 February 2024
- journal article
- letter
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 38, 100871
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic AreaEurosurveillance, 2023
- Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20Journal of Antimicrobial Chemotherapy, 2023
- Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infectionsJournal of Antimicrobial Chemotherapy, 2023
- Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted InfectionsNew England Journal of Medicine, 2023
- Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trialThe Lancet Infectious Diseases, 2018
- A Trial of Minocycline Given after Exposure to Prevent GonorrheaNew England Journal of Medicine, 1979